ChinaBio(R) LLC Release: China To Stage Only 100 IPOS During The Rest Of 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 22, 2014 -- China will limit IPOs to just 100 for the remainder of 2014, even though more than 550 companies have filed to raise capital on China’s public exchanges. After 2013, when all IPOs were halted, observers expected a flood of new offerings this year. But regulators seem to fear anything that might destabilize the market. China’s stock prices have been heading lower since 2010. Apparently, regulators are worried that investors would sell their existing holdings to buy new shares, sending prices lower still. More details....

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC